Feline Leukemia Virus: Pathophysiology, Prevention, and Treatment

References

• Jarrett W FH, Crawford E, Martin W B. Leukemia in the cat. A virus-like particle associated with leukemia (lymphosarcoma). Nature 1964; 202: 567–569
   PubMed Web of Science ®Google Scholar
• Benveniste R E, Sherr C J, Todaro G J. Evaluation of type-C viral genes: origin of feline leukemia virus. Science 1975; 190: 886–888
   PubMed Web of Science ®Google Scholar
• Stephenson J R, Devare S G, Reynolds F H. Translational products of RNA tumor viruses. Adv Cancer Res 1978; 27: 1–53
   PubMedGoogle Scholar
• Russell P H, Jarrett O. The occurrence of feline leukemia virus neturalizing antibodies in cats. Int J Cancer 1978; 22: 351–357
   PubMed Web of Science ®Google Scholar
• Sarma P S, Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology 1973; 54: 160–170
   PubMed Web of Science ®Google Scholar
• Jarrett O, Hardy WD, Jr, Golder M C. The frequency of occurrence of feline leukemia virus subgroups in cats. Int J Cancer 1978; 21: 334–337
   PubMed Web of Science ®Google Scholar
• Essex M, Klein G, Snyder S P. Correlation between humoral antibody and regression of tumors induced by feline sarcoma virus. Nature 1971; 233: 195–196
   PubMed Web of Science ®Google Scholar
• Sliski A H, Essex M, Meyer C. Feline oncornavirus-associated cell membrane antigen: Expression in transformed nonproducer mink cells. Science 1977; 196: 1336–1339
   PubMed Web of Science ®Google Scholar
• Essex M, Sliski A H, Hardy WD, Jr. Feline oncornavirus-associated cell membrane antigen: A tumor specific cell surface marker. Advances in Comparative Leukemia Research, P. Benvelzen. FJsevier/North-Holland, New York 1978; 337–340
   Google Scholar
• Essex M, Sliski A H, Cotter S M. Immunosurveillance against naturally occurring feline leukemia. Science 1975; 190: 790–792
   PubMed Web of Science ®Google Scholar
• Grant C K, Pickard R C, Madewell B R. Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease. Cancer Res 1979; 39: 75–81
   PubMed Web of Science ®Google Scholar
• Snyder HW, Jr, Singhal M C, Zuckerman E E. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-Cgp70. Virology 1983; 131: 315–327
   PubMed Web of Science ®Google Scholar
• Vedbrat S S, Rasheed S, Lutz H. Feline oncornavirus-associated cell membrane antigen: A viral and not a cellularly coded transformation-specific antigen of cat lymphomas. Virology 1983; 124: 445–461
   PubMed Web of Science ®Google Scholar
• Cotter S M, Gilmore C A, Rollins C. Multiple cases of feline leukemia and feline infectious peritonitis in a household. J Am Vet Med Assoc 1973; 162: 1054–1058
   PubMed Web of Science ®Google Scholar
• Cotter S M, Essex M, Hardy WD, Jr. Serological studies of normal and leukemic cats in a multiple-case household. Cancer Res 1974; 34: 1061–1069
   PubMed Web of Science ®Google Scholar
• Francis D P, Essex M, Gayzagian D. Feline leukemia virus: survival under home and laboratory conditions. J Clin Microbiol 1979; 9: 154–156
   PubMed Web of Science ®Google Scholar
• Hoover E A, Olsen R G, Hardy WD, Jr. Felne leukemia virus infection: Age-related variation in response of cats to experimental infection. J Natl Cancer Inst 1967; 57: 365–369
   Google Scholar
• Rojko J L, Hoover E A, Quackenbush S L. Reactivation of latent feline leukemia virus infection. Nature 1982; 298: 385–388
   PubMed Web of Science ®Google Scholar
• Pedersen N C, Meric S M, Johnson L. The clinical significance of latent feline leukemia virus infection in cats. Feline Pract 1984; 14: 32–48
   Google Scholar
• Pacitti A M, Jairett O, Hay D. Transmission of feline leukaemia virus in the milk of a non-viremic cat. Vet Record 1986; 118: 381–384; 14
   PubMed Web of Science ®Google Scholar
• Rezanka L I, Rojko J L, Neil J C. Feline leukenia virus, pathogenesis of neoplastic and atrophic lymphoid diseases. Cancer Invest 1992; 10(5), to be published
   PubMed Web of Science ®Google Scholar
• Cotter S M, Hardy WD, Jr, Essex M. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J Am Vet Med Assoc 1975; 166: 449–454
   PubMed Web of Science ®Google Scholar
• Hardy WD, Jr, McClelland A J, Zuckerman E E. Prevention of contagious spread of feline leukemia virus and development of leukemia in pet cats. Nature 1976; 263: 326–328
   PubMed Web of Science ®Google Scholar
• Essex M, Hardy WD, Jr, Cotter S M. Naturally occurring persistent feline oncornavirus infections in the absence of disease. Infect Immun 1875; 11: 470–475
   Google Scholar
• Swenson C L, Kociba G J, Mathes L E. Prevalence of disease in nonviremic cats previously exposed to feline leukemia virus. J Am Vet Med Assoc 1990; 196: 1049–1052
   PubMed Web of Science ®Google Scholar
• Shin T Y, Scolnick E M. Molecular biology of mammalian sarcoma viruses. Viral Oncology, G Klein. Raven Press, New York 1980; 135–160
   Google Scholar
• Francis D P, Essex M, Cotter S M. Epidemiologic association between virus-negaive feline leukemia and the horizontally transmitted feline leukemia virus. Cancer Lett 1981; 12: 37–42
   PubMed Web of Science ®Google Scholar
• Hardy WD, Jr, McClelland A J, Zuckerman E E. Development of virus non-producing lymphosarcoma in pet cats exposed to FeLV. Nature 1980; 288: 90–92
   PubMed Web of Science ®Google Scholar
• Cockerell G L, Krakowka S, Hoover E A. Characterization of feline T- andB-lymphocytes and identification of an experimentally induced T-cell neoplasm in the cat. J Natl Cancer Inst 1976; 57: 907–913
   PubMed Web of Science ®Google Scholar
• Rojko J L, Kocba G J, Abkowitz K L. Feline lymphomas: Immunological and cytochemical characterization. Cancer Res 1989; 49: 345–351
   PubMed Web of Science ®Google Scholar
• Valli V E, McSherry B J, Bunham B M. Kstocytology of lymphoid tumors in the dog, cat, and cow. Vet Pathol 1981; 18: 494–512
   PubMed Web of Science ®Google Scholar
• Jones T C. Chromosomal analyses of feline lymphomas. Symposium on Comparative Morphology of Hematopoietic Neoplasms. Natl Cancer Inst Monogr 32. National Cancer Institute, Bethesda 1969; 95
   Google Scholar
• Hardy WD, Jr. Feline leukemia virus diseases. Feline Leukemia Virus, WD Hardy, Jr, M Essex, AJ McClelland. Elsevier/North-Holland, New York 1980; 3–31
   Google Scholar
• Theilen G H, Madewell B R. Hematopoietic neoplasms. Veterinary Cancer Medicine Second edition, GH Theilen, BR Madewell. Lea and Febiger, Philadelphia 1987; 354–381
   Google Scholar
• Cotter S M. Treatment of lymphoma and leukemia with cyclophosphamide, vincristine, and prednisone: n. Treatment of cats. J Am Animal Hosp Assoc 1983; 19: 166–172
   Web of Science ®Google Scholar
• Mooney S C, Hayes A A, MacEwen E G. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977–1981). J Am Vet Med Assoc 1989; 194: 696–699
   PubMed Web of Science ®Google Scholar
• Cotter S M, Essex M, McLane M F. Chemotherapy and passive immunotherapy in naturally occurring feline mediastinal lymphoma. la Feline Leukemia Virus, WD Hardy, Jr, M Essex, AJ McClelland. Elsevier/North-Holland, New York 1980; 219–225
   Google Scholar
• Kassel R L, Old L J, Day N H. Plasma-mediated leukemia cell destruction: Concentration and purification of the antileukemia factor. Proc Soc Exp Biol Med 1977; 155: 230–233
   PubMed Web of Science ®Google Scholar
• Harper H D, Sjoquist J, Hardy WD, Jr. Antitumor activity of protein A administered intravenously to pet cats with leukemia and lymphosarcoma. Cancer 1985; 55: 1863–1867
   PubMed Web of Science ®Google Scholar
• Jones F R, Yoshida L H, Ladiges W C. Treatment of feline leukemia and reversal of FeLV by ex vivo removal of IgG. Cancer 1980; 46: 675–684
   PubMed Web of Science ®Google Scholar
• MacEwen E G. Current Concepts in cancer therapy: Biologic therapy and chemotherapy. Semin Vet Med Surg 1986; 1: 5–16
   PubMedGoogle Scholar
• Hoover E A, Quackerbush S L, Ackley C D. Lymphocyte subset alterations in cats infected with immunodeficiency disease inducing chimeras of FeLV-FAIDS. Proc XlVth Int Symp Leukemia and Related Disease. 1989, 17
   Google Scholar
• Neil J C, Onions D E. Feline leukemia viruses: Molecular biology and pathogenesis. Anticancer Res 1985; 5: 49–63
   PubMed Web of Science ®Google Scholar
• Snyder S P, Theilen G H. Transmissible feline fibrosarcoma. Nature 1969; 221: 1074–1075
   PubMed Web of Science ®Google Scholar
• Hardy WD, Jr. The biology and virology of the feline sarcoma viruses. Feline Leukemia Virus, WD Hardy, Jr, M Essex, AJ McClelland. Elsevier/North-Holland, New York 1980; 79–120
   Google Scholar
• McCullough B, Schaller J, Shadduck J A. Induction of malignant melanomas associated with fibrosarcomas in gnotobiotic cats inoculated with Gardner feline fibrosarcoma virus. J Natl Cancer Inst 1972; 48: 1893–1896
   PubMed Web of Science ®Google Scholar
• Albert D M, Shadduck J A, Letal Craft J. Feline uveal melanoma model induced with feline sarcoma virus. Invest Ophthalmal Vis Sci 1981; 20: 606–624
   PubMed Web of Science ®Google Scholar
• Albert D M, Lahar M, Colby E D. Retinal neoplasia and dysplasia I. Induction by feline leukemia virus. Invest Ophthalmol Vis Sci 1977; 16: 325–337
   PubMed Web of Science ®Google Scholar
• Rickard C G, Post J E, DeNoronha F. A transmissible virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst 1969; 42: 987–1014
   PubMed Web of Science ®Google Scholar
• Mackey L, Jarrett W, Jarrett O. Anemia associated with feline leukemia virus infection in cats. J Natl Cancer Inst 1975; 54: 209–217
   PubMed Web of Science ®Google Scholar
• Cotter S M. Anemia associated with feline leukemia virus infection. J Am Vet Med Assoc 1979; 175: 1191–1194
   PubMed Web of Science ®Google Scholar
• Onions D, Jarrett O, Testa N. Selective effect of feline leukemia virus on early erythroid precursors. Nature 1982; 296: 156–158
   PubMed Web of Science ®Google Scholar
• Wardrop K J, Kramer J W, Abkowitz J L. Quantitative studies of erythropoiesis in clinically normal, phlebotomized, and feline leukemia virus infected cats. Am J Vet Res 1986; 47: 2274–2277
   PubMed Web of Science ®Google Scholar
• Weiser M G, Kociba G J, Jacobs R M. Erythrocyte macrocytosis in feline leukemia virus-associated anemia. Vet Pathol 1983; 20: 687–697
   PubMed Web of Science ®Google Scholar
• Kiehl A R, Fettman M J, Quackenbush S L. Effects of feline leukemia virus on neutrophil chemotaxis in vitro. Am J Vet Res 1987; 48: 76–80
   PubMed Web of Science ®Google Scholar
• Lafrado L J, Olsen R J. Demonstration of depressed polymorphonuclear leukocyte function in nonviremic FeLV-infected cats. Cancer Invest 1986; 4: 297–300
   PubMed Web of Science ®Google Scholar
• Perryman L E, Hoover E A, Yohn D S. Immunologic reactivity of the cat: immunosuppression in experimental feline leukemia. J Natl Cancer Inst 1972; 49: 1357–1365
   PubMed Web of Science ®Google Scholar
• Cockerell G L, Hoover E A, Krakowka S. Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat. J Natl Cancer Inst 1976; 57: 1095–1099
   PubMed Web of Science ®Google Scholar
• Cockerell G L, Hoover E A. Inhibition of normal lymphocyte mitogenic reactivity by serum from feline leukemia virus-infected cats. Cancer Res 2977; 37: 3985–3989
   Google Scholar
• Mullins J I, Cs Chen, Hoover E A. Disease-specific and tissue-specific production of unintegrated feline leukemia virus variant DNA in feline AIDS. Nature 1986; 319: 333–336
   PubMed Web of Science ®Google Scholar
• Tompkins M B, Ogilvie G K, Gast A M. Interleukin-2 suppression in cats naturally infected with feline leukemia virus. J Biol Response Mod 1989; 8: 86–96
   PubMedGoogle Scholar
• Wernicke D, Trainin Z, Ungar-Waron H. Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus. J Virol 1986; 60: 669–673
   PubMed Web of Science ®Google Scholar
• Moore F M, Emerson W E, Cotter S M. Distinctive peripheral lymph node hyperplasia of young cats. Vet Pathol 1986; 23: 386–391
   PubMed Web of Science ®Google Scholar
• Pedersen N C, Ho E W, Brown M L. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1986; 235: 790–793
   Web of Science ®Google Scholar
• Jarrett W, Mackey L, Jarrett O. Antibody response and virus survival in cats vaccinated against feline leukemia. Nature 1974; 248: 230–232
   PubMed Web of Science ®Google Scholar
• Jarrett W, Jarrett O, Mackey L. Vaccination against feline leukaemia using a cell membrane antigen system. Int J Cancer 1975; 16: 134–141
   PubMed Web of Science ®Google Scholar
• Olsen R G, Hoover E A, Mathes L E. Immunization against feline oncornavirus disease using a killed tumor cell vaccine. Cancer Res 1976; 36: 3642–3646
   PubMed Web of Science ®Google Scholar
• Lewis M G, Mathes L E, Olsen R G. Protection against feline leukemia by vaccination with a subunit vaccine. Infect Immun 1981; 34: 888–894
   PubMed Web of Science ®Google Scholar
• Pedersen N C, Johnson L, Ott R L. Evaluation of a commercial feline leukemia virus vaccine for immunogenicity and efficacy. Feline Pract 1985; 15: 7–20
   Google Scholar
• Legendre A M, Mitchner K L, Potgieter L ND. Efficacy of a feline leukemia virus vaccine in a natural exposure challenge. J Vet Int Med 1990; 4: 92–98
   PubMed Web of Science ®Google Scholar
• Pollock R VH, Scarlett J M. Randomized blind trial of a commercial FeLV vaccine. J Am Vet Med Assoc 1990; 196: 611–616
   PubMed Web of Science ®Google Scholar
• Rosenthal R C, Dworkis A S. Adverse reactions to leukocell. J Am Animal Hosp Assoc 1987; 23: 515–518
   Web of Science ®Google Scholar
• Salerno R A, Lehman E D, Larson V M. Feline leukemia virus envelope glycoprotein vaccine: Preparation and evaluation of immunizing potency in the guinea pig and cat. J Natl Cancer Inst 1978; 61: 1487–1493
   PubMed Web of Science ®Google Scholar
• Kanki A J, Essex M. Animal models of HTLV-III/LAV infection and AIDS. AIDS, Modern Concepts and Therapeutic Challenges, S Broder. Marcel Dekker, New York 1987; 63–73
   Google Scholar
• Cogan D C, Cotter S M, Kitchen L W. Effect of suramin on serum viral replication in feline leukemia virus-infected pet cats. J Am Vet Med Assoc 1986; 47: 2230–2232
   Web of Science ®Google Scholar
• Tavares L, Roneker C, Johnston K. 3′-Azido-3′- deoxy-thymidine in feline leukemia virus-infeted cats: a model for therapy and prophylaxis of AIDS. Cancer Res 1987; 47: 3190–3194
   PubMed Web of Science ®Google Scholar
• Zeidner N S, Strobel J D, Perigo N A. Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2′,3′-dideoxycytidine. Antiviral Res 1989; 7: 147–160
   Google Scholar
• Billiau A, Herremans H, Allen P T. Trapping of oncornavirus particles at the surface of interferon-treated cells. Virology 1976; 73: 537–542
   PubMed Web of Science ®Google Scholar
• Jameson P, Essex M. Inhibition of FeLV replication by human leukocyte interferon. Antiviral Res 1983; 3: 115–120
   PubMed Web of Science ®Google Scholar
• Beck E R. Clinical and experimental interferon therapy in the cat. Proc Vet Cancer Soc 1985; 21
   Google Scholar
• Engleman R W, Fulton R W, Good R A. Suppression of gamma interferon production by inactivated feline leukemia virus. Science 1985; 227: 1368–1370
   PubMed Web of Science ®Google Scholar
• Dubey J P, Staunton D, Azocar J. Natural killer activity against retrovirus infected cells: Dichotomy in NK sensitivity of infected T- and B-cells. Clin Immunol Immunopath 1982; 23: 215–223
   PubMedGoogle Scholar
• Schafer T W, Lieverman M, Cohen M. Interferon administered orally: Protection of neonatal mice from lethal virus challenge. Science 1972; 176: 1326–1327
   PubMed Web of Science ®Google Scholar
• Zeidner N S, Mathiason-Dubard C K, Rose L M. Zidovudine in combination with alpha interferon, interluekin-2, and activated immune lymphocytes as therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS). Proc XTVth Int Symp Comp Res Leukemia and Related Diseases. 1989, 102
   Google Scholar
• Gasper P W, Fulton R, Thrall M A. Treatment of feline leukemia virus infection with allogeneic marrow transplantation and zidovudine. Proc XlVth Int Symp Comp Res Leukemia and Related Diseases. 1989, 94
   Google Scholar
• Kitchen L W, Mather J F. Hematologic effects of short-term oral diethylcarbamazine treatment given to chronically feline leukemia virus-infected cats. Cancer Lett (Ireland) 1989; 45: 183–187
   PubMed Web of Science ®Google Scholar
• Liu W T, Ra Good, Trang L Q. Remission of leukemia and loss of feline leukemia virus in cats injected with staphylococcus protein A: Association with increased circulating interferon and complement-dependent cytotoxic antibody. Proc Natl Acad Sci (USA) 1984; 81: 6471–6475
   PubMed Web of Science ®Google Scholar
• Schafer W, Bolognesi D P, DeNoronha F. Immuno-prophylaxis and therapy of C-type oncornaviral diseases in mice and cats. Med Microbiol Immunol 1977; 164: 217–229
   PubMed Web of Science ®Google Scholar
• Cotter S M, Grant C K, Goldstein M A. Treatment of naturally occurring feline leukemia virus infections with monoclonal antibodies. Proc Am College Vet Int Med 1986; 13: 3–6
   Google Scholar